메뉴 건너뛰기




Volumn 124, Issue 2, 2004, Pages 69-75

Pharmacological role of HB-EGF shedding by angiotensin II in cardiomyocytes

Author keywords

Angiotensin II; Cardiomyocyte; EGF receptor; HB EGF; Metalloproteinase

Indexed keywords

ANGIOTENSIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; G PROTEIN COUPLED RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; KBR 7785; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

EID: 4143129790     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.124.69     Document Type: Review
Times cited : (2)

References (5)
  • 1
    • 0033599039 scopus 로고    scopus 로고
    • EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF
    • Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 1999;402:884-888.
    • (1999) Nature , vol.402 , pp. 884-888
    • Prenzel, N.1    Zwick, E.2    Daub, H.3    Leserer, M.4    Abraham, R.5    Wallasch, C.6
  • 2
    • 0036152858 scopus 로고    scopus 로고
    • Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
    • Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T, et al. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med. 2002;8:35-40.
    • (2002) Nat Med , vol.8 , pp. 35-40
    • Asakura, M.1    Kitakaze, M.2    Takashima, S.3    Liao, Y.4    Ishikura, F.5    Yoshinaka, T.6
  • 4
    • 0036099675 scopus 로고    scopus 로고
    • ErbB2 is essential in the prevention of dilated cardiomyopathy
    • Crone SA, Zhao YY, Fan L, Gu Y, Minamisawa S, Liu Y, et al. ErbB2 is essential in the prevention of dilated cardiomyopathy. Nat Med. 2002;8:459-465.
    • (2002) Nat Med , vol.8 , pp. 459-465
    • Crone, S.A.1    Zhao, Y.Y.2    Fan, L.3    Gu, Y.4    Minamisawa, S.5    Liu, Y.6
  • 5
    • 0034682589 scopus 로고    scopus 로고
    • Trastuzumab in the treatment of metastatic breast cancer: Anticancer therapy versus cardiotoxicity
    • Feldman AM, Lorell BH, Reis SE. Trastuzumab in the treatment of metastatic breast cancer: anticancer therapy versus cardiotoxicity. Circulation. 2000;102:272-274.
    • (2000) Circulation , vol.102 , pp. 272-274
    • Feldman, A.M.1    Lorell, B.H.2    Reis, S.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.